Caresyntax Raises $180 Million Funding to Accelerate Growth . . . Caresyntax, a vendor-neutral precision surgery platform, raises $180 million in Series C funding, backed by Symbiotic Capital, MTIP AG, and Pictet Alternative Advisors, to advance AI-powered surgical solutions
Federato launches AI-native platform after $100m Series D With more than $180m now raised to date, the Series D funding will support global expansion and continued product innovation Growth Equity at Goldman Sachs Alternatives managing director Jade Mandel said, “Our diligence in P C insurance revealed that Federato’s AI-native platform delivers a step change in ROI and efficiency compared to
Federato, which provides AI-powered insurance lifecycle . . . Federato, which provides AI-powered insurance lifecycle software, raised a $100M Series D led by Goldman Sachs Alternatives, taking its total funding to $180M+ — Federato, the AI-native insurance software provider, has secured $100m in its Series D round to accelerate the adoption …
Caresyntax Secures $180M to Advance Precision Surgery Platform – Caresyntax, a leader in vendor-neutral precision surgery platforms raises $180M in funding, comprised of $80M in equity and up to $100M in growth debt, will fuel the company’s continued growth
surgical. ai Backs Caresyntax in $180 Million Series C Funding SAN FRANCISCO– (BUSINESS WIRE)– surgical ai, a permanent capital vehicle focused on surgical automation, robotics and software, today announced its meaningful participation in a $180 million Series C round for Caresyntax